{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:05:46Z","timestamp":1792112746661,"version":"4.4.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1097\/mjt.0b013e3182491e29","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T18:16:39Z","timestamp":1348596999000},"page":"e90-e93","source":"Crossref","is-referenced-by-count":8,"title":["Acanthosis Nigricans During Treatment With Aripiprazole"],"prefix":"10.1097","volume":"21","author":[{"given":"Peter","family":"Manu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Al-Dhaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Dargani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":". Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"R2-23-20210202","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.2011.10111609","article-title":"; Schizophrenia Trials Network. A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of Antipsychotics for Metabolic Problems (CAMP).","volume":"168","author":"Stroup","year":"2011","journal-title":"Am J Psychiatry"},{"key":"R3-23-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.jcp.0000130558.86125.5b","article-title":"A comparison of risperidone-induced weight gain across the age span.","volume":"24","author":"Safer","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R4-23-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.npp.1300327","article-title":". A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth.","volume":"29","author":"Sikich","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R5-23-20210202","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":". Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorders: findings from the treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study.","volume":"165","author":"Sikich","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R6-23-20210202","first-page":"26","article-title":"Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.","volume":"69","author":"Correll","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R7-23-20210202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/cap.2007.0138","article-title":". Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.","volume":"18","author":"Castro-Fornieles","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R8-23-20210202","first-page":"2322","article-title":". Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302:1765-1773.","volume":"302","author":"Correll","year":"2009","journal-title":"Erratum in: JAMA"},{"key":"R9-23-20210202","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":". Metabolomic mapping of atypical antipsychotic effects in schizophrenia.","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R10-23-20210202","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1440-1754.2007.01272.x","article-title":". Significance of Acanthosis nigricans in childhood obesity.","volume":"44","author":"Guran","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"R11-23-20210202","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.4065\/79.12.1571","article-title":"Acanthosis nigricans.","volume":"79","author":"Gibson","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"R12-23-20210202","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":". Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R13-23-20210202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejim.2010.05.015","article-title":". Predictors of insulin resistance in the obese with metabolic syndrome.","volume":"21","author":"Manu","year":"2010","journal-title":"Eur J Intern Med"},{"key":"R15-23-20210202","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4088\/JCP.09m05933","article-title":". Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.","volume":"72","author":"Marcus","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R16-23-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc10-1197","article-title":". Metabolic risk and health behaviors in minority youth at risk for type 2 diabetes.","volume":"34","author":"Holl","year":"2011","journal-title":"Diabetes Care"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3182491e29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:36:58Z","timestamp":1620963418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201405000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182491e29","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}